Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $5.2000 (4.84%) ($4.5700 - $5.4800) on Thu. Apr. 30, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 20.37% (three month average) | RSI | 58 | Latest Price | $5.2000(4.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SONN declines -0.4% a day on average for past five trading days. | Weekly Trend | SONN declines -9.8% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) XBI(27%) VXX(-32%) HYG(63%) JNK(67%) (0%) | Factors Impacting SONN price | SONN will decline at least -10.185% in a week (0% probabilities). JNK(67%) HYG(63%) VXX(-32%) XBI(27%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -10.185% (StdDev 20.37%) | Hourly BBV | 0 () | Intraday Trend | 4.4% | | | |
|
1 - 5 Day Possible Target | $-19.06(-466.54%) | Resistance Level | $5.57 | 5 Day Moving Average | $5.03(3.38%) | 10 Day Moving Average | $5.3(-1.89%) | 20 Day Moving Average | $5.57(-6.64%) | To recent high | -80.4% | To recent low | 4% | Market Cap | $48m | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |